| Drug Name: | Infliximab |
|---|
| Drug Class: | TNF-alpha inhibitor |
|---|
| Mechanism of Action: | - Binds to TNF-alpha and prevents it from binding to its receptors, thereby reducing inflammation
|
|---|
| Use: | - Treatment of autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, and ankylosing spondylitis
|
|---|
| Side Effects: | - Increased risk of infections
- Infusion reactions such as fever, chills, and headache
- Development of antibodies against the drug
- Increased risk of lymphoma and other cancers
|
|---|
| Contraindications: | - Active infections
- Heart failure
- Multiple sclerosis
- Pregnancy and breastfeeding
|
|---|
| Specialty: | - Rheumatology
- Gastroenterology
- Dermatology
|
|---|